GluSense's Unattributed Round

GluSense raised a round of funding on February 15, 2017. Investors include JDRF.

GluSense is a medical device company developing a long lasting injectable glucose sensor for treatment of Type 1 Diabetes (T1D). GluSense is developing a miniature injectable continuous glucose sensor…

Articles about GluSense's Unattributed Round: